1501153-67-8 Usage
Description
(3-amino-2,6-difluoro-phenyl)-[5-bromo-1-(2,6-dichlorobenzoyl)pyrrolo[2,3-b]pyridin-3-yl]methanone is a complex heterocyclic compound characterized by a pyrrolopyridine core structure. It features a 2,6-difluoro-phenyl group, a 2,6-dichlorobenzoyl group, a bromine atom, and an amino group. (3-amino-2,6-difluoro-phenyl)-[5-bromo-1-(2,6-dichlorobenzoyl)pyrrolo[2,3-b]pyridin-3-yl]methanone holds promise in medicinal chemistry due to its unique structural attributes, which may enable the development of pharmaceuticals that target specific biological pathways or molecular targets.
Uses
Used in Pharmaceutical Development:
(3-amino-2,6-difluoro-phenyl)-[5-bromo-1-(2,6-dichlorobenzoyl)pyrrolo[2,3-b]pyridin-3-yl]methanone is utilized as a key intermediate in the synthesis of novel pharmaceuticals. Its unique structural features make it a valuable candidate for the development of drugs that can modulate specific biological pathways or engage with particular molecular targets, potentially leading to treatments for various diseases and conditions.
Further research is necessary to explore the full spectrum of biological activities and therapeutic properties that this compound may possess, ensuring its potential is fully realized in the field of medicinal chemistry.
Check Digit Verification of cas no
The CAS Registry Mumber 1501153-67-8 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,5,0,1,1,5 and 3 respectively; the second part has 2 digits, 6 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 1501153-67:
(9*1)+(8*5)+(7*0)+(6*1)+(5*1)+(4*5)+(3*3)+(2*6)+(1*7)=108
108 % 10 = 8
So 1501153-67-8 is a valid CAS Registry Number.
1501153-67-8Relevant articles and documents
BRAF DEGRADERS
-
, (2022/02/06)
Present invention provides compounds that cause specifically the degradation of BRAF. The present compounds are useful for the treatment of various cancers.
PROTEIN KINASE INHIBITORS FOR PROMOTING LIVER REGENERATION OR REDUCING OR PREVENTING HEPATOCYTE DEATH
-
, (2018/08/12)
The invention relates to MKK4 (mitogen-activated protein kinase 4) and their use in promoting liver regeneration or reducing or preventing hepatocyte death. The MKK4 inhibitors selectively inhibit protein kinase MKK4 over protein kinases JNK and MKK7.
SOLID FORMS OF A COMPOUND FOR MODULATING KINASES
-
, (2016/12/16)
Solid forms of Compound I (and its S-enantiomer, Compound II), active on protein kinases, were prepared and characterized: Also provided are methods of using the solid forms.
